Technical Analysis for 0RKL - Xvivo Perfusion AB

Grade Last Price % Change Price Change
A 373.00 5.14% 18.25
0RKL closed up 5.14 percent on Friday, April 26, 2024, on 39 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Slingshot Bullish Bullish Swing Setup 5.14%
Volume Surge Other 5.14%
Upper Bollinger Band Walk Strength 5.14%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Xvivo Perfusion AB Description

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.


Classification

Is 0RKL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 381.5
52 Week Low 205.5
Average Volume 8,366
200-Day Moving Average 283.59
50-Day Moving Average 288.69
20-Day Moving Average 309.78
10-Day Moving Average 335.86
Average True Range 15.39
RSI (14) 72.83
ADX 33.21
+DI 47.33
-DI 17.05
Chandelier Exit (Long, 3 ATRs) 335.32
Chandelier Exit (Short, 3 ATRs) 309.86
Upper Bollinger Bands 375.38
Lower Bollinger Band 244.18
Percent B (%b) 0.98
BandWidth 42.35
MACD Line 19.91
MACD Signal Line 13.70
MACD Histogram 6.2036
Fundamentals Value
Market Cap 98.48 Million
Num Shares 26.4 Million
EPS 0.24
Price-to-Earnings (P/E) Ratio 1573.84
Price-to-Sales 0.12
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 395.50
Resistance 3 (R3) 394.17 385.33 391.75
Resistance 2 (R2) 385.33 379.60 386.00 390.50
Resistance 1 (R1) 379.17 376.06 382.25 380.50 389.25
Pivot Point 370.33 370.33 371.88 371.00 370.33
Support 1 (S1) 364.17 364.60 367.25 365.50 356.75
Support 2 (S2) 355.33 361.06 356.00 355.50
Support 3 (S3) 349.17 355.33 354.25
Support 4 (S4) 350.50